Contineum Therapeutics Inc (CTNM)
NASDAQ
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|
USD ($) | |||
Total Assets | 123.56M | 221.36M | 216.03M |
Total Current Assets | 119.71M | 220.32M | 215.14M |
Cash and Equivalents | 16.26M | 77.23M | 40.89M |
Total Non-Current Assets | 3.85M | 1.04M | 891k |
Total Liabilities | 6.57M | 3.85M | 5.81M |
Total Current Liabilities | 6.23M | 3.74M | 5.81M |
Total Non-Current Liabilities | 339k | 113k | 0 |
Common Equity | 2k | 26k | 26k |
Retained Earnings | -83.56M | -92.57M | -102.84M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Assets | 130.39M |
Total Current Assets | 127.71M |
Cash and Equivalents | 15.53M |
Total Non-Current Assets | -67.94M |
Total Liabilities | 5.7M |
Total Current Liabilities | 5.48M |
Total Non-Current Liabilities | 218k |
Total Equity | -67.94M |
Common Equity | 13k |
Retained Earnings | -75.14M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.